Is TTK Healthcare a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that TTK Healthcare Ltd is a average quality company .

Is TTK Healthcare undervalued or overvalued?

The key valuation ratios of TTK Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is TTK Healthcare share price return in the past 10 years?

TTK Healthcare Ltd share price has appreciated 2.9% annually (CAGR) over the past ten years.

Is TTK Healthcare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of TTK Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

TTK Healthcare Ltd - Stock Valuation and Financial Performance

Name: TTK Healthcare
Brand: TTK Healthcare

BSE: 507747 | NSE: TTKHLTCARE | Diversified | Small Cap

Place order

TTK Healthcare Share Price

₹1,324.70 -20.30 -1.51%
as on 18-Jul'25 16:59

TTK Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 507747 | NSE: TTKHLTCARE | Diversified | Small Cap

Place order

TTK Healthcare Share Price

₹1,324.70 -20.30 -1.51%
as on 18-Jul'25 16:59

10 Year X-Ray of TTK Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	23.9%	18.6%	15.4%	15.5%	8.3%	8.4%	8.6%	10.1%	8.7%	10.6%	-
Value Creation Index ⓘ	0.7	0.3	0.1	0.1	-0.4	-0.4	-0.4	-0.3	-0.4	-0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	519	528	578	628	646	476	599	725	753	801	801
Sales YoY Gr.	-	1.7%	9.4%	8.7%	2.9%	-26.3%	25.9%	21%	3.8%	6.5%	-
Adj EPS ⓘ	29.2	23.4	12.9	17.2	8.7	22.1	11.7	31.4	44.4	50.8	57.8
YoY Gr.	-	-20%	-44.7%	32.9%	-49.6%	155%	-46.9%	167.9%	41.3%	14.5%	-
BVPS (₹) ⓘ	169.7	197.1	161.8	174.8	173.1	205.4	230.2	671.6	705.2	750.6	750.6
Adj Net Profit ⓘ	22.7	18.1	18.3	24.3	12.2	31.2	16.6	44.4	62.7	71.8	82
Cash Flow from Ops. ⓘ	37.4	17.8	25.3	17.3	19.8	96.4	45	-24.8	-4.9	-4	-
Debt/CF from Ops. ⓘ	1	1.3	1.9	1.7	1.4	0.2	0.5	-1	-4.3	-5.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5%	4.4%	10.2%	6.5%
Adj EPS ⓘ	6.4%	42.5%	63.1%	14.5%
BVPSⓘ	18%	34.1%	48.3%	6.4%
Share Price	2.9%	25.4%	15.7%	-9.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	17.8	12.4	9.4	10	4.9	11.5	5.3	6.9	6.4	7	7.7
Op. Profit Mgn % ⓘ	7.8	7.3	7.4	7.9	4.4	4.1	3.7	4.3	5	4.4	4.4
Net Profit Mgn % ⓘ	4.4	3.4	3.2	3.9	1.9	6.6	2.8	6.1	8.3	9	10.2
Debt to Equity ⓘ	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0	0	0	0
Working Cap Days ⓘ	73	70	76	93	102	134	97	95	131	162	262
Cash Conv. Cycle ⓘ	33	17	1	17	30	30	14	15	26	32	211

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.70%

Sales growth is growing at healthy rate in last 3 years 10.18%

Net Profit is growing at healthy rate in last 3 years 63.06%

Sales growth is not so good in last 4 quarters at 6.56%

Latest Financials - TTK Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	57.8	-
TTM Sales (₹ Cr.)	801	-
BVPS (₹.) ⓘ	750.6	-
Reserves (₹ Cr.) ⓘ	1,047	-
P/BV ⓘ	1.76	-
PE ⓘ	22.92	-

From the Market
52 Week Low / High (₹)	991.00 / 1923.00
All Time Low / High (₹)	11.50 / 1923.00
Market Cap (₹ Cr.)	1,872
Equity (₹ Cr.)	14.1
Face Value (₹)	10
Industry PE ⓘ	151.2

Management X-Ray of TTK Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of TTK Healthcare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of TTK Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	519	528	578	628	646	476	599	725	753	801
Operating Expenses ⓘ	478	489	535	578	617	457	577	694	715	767
Manufacturing Costs	16	19	26	28	33	29	35	40	44	50
Material Costs	229	243	242	263	260	209	281	348	338	369
Employee Cost	81	88	120	131	144	94	103	123	133	151
Other Costs ⓘ	152	139	147	157	181	125	158	183	200	197
Operating Profit ⓘ	40	38	43	50	28	19	22	31	37	35
Operating Profit Margin (%)	7.8%	7.3%	7.4%	7.9%	4.4%	4.1%	3.6%	4.3%	5.0%	4.3%
Other Income ⓘ	6	6	8	8	9	10	16	48	63	71
Interest ⓘ	3	3	5	3	3	2	3	5	3	3
Depreciation ⓘ	7	12	15	15	14	13	13	13	13	8
Exceptional Items ⓘ	0	0	0	0	0	8	2	0	0	14
Profit Before Tax ⓘ	36	29	30	39	19	23	25	62	84	108
Tax ⓘ	13	10	12	15	7	-14	6	17	21	27
Profit After Tax	23	19	18	24	12	37	19	45	63	82
PAT Margin (%)	4.4%	3.6%	3.1%	3.9%	1.9%	7.7%	3.1%	6.2%	8.3%	10.2%
Adjusted EPS (₹)	29.2	24.1	12.9	17.3	8.7	26.0	13.1	31.6	44.5	57.8
Dividend Payout Ratio (%)	17%	21%	39%	29%	34%	23%	76%	32%	22%	17%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund	136	157	233	251	249	295	330	953	1,001	1,065
Share Capital ⓘ	8	8	14	14	14	14	14	14	14	14
Reserves ⓘ	128	150	219	237	235	281	316	939	987	1,051
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	23	23	47	28	28	18	20	26	21	22
Long Term Debt	1	1	1	0	0	0	0	0	0	0
Short Term Debt	22	22	46	28	28	18	20	26	21	22
Trade Payables	33	67	86	73	87	98	103	111	102	107
Others Liabilities ⓘ	110	38	36	59	63	78	98	76	76	81
Total Liabilities ⓘ	303	285	403	411	427	488	551	1,166	1,201	1,275
Fixed Assets
Gross Block	146	111	141	144	149	159	165	164	178	183
Accumulated Depreciation	40	12	31	46	60	73	85	93	103	103
Net Fixed Assetsⓘ	106	99	110	98	89	85	80	71	75	81
CWIP ⓘ	1	0	1	2	9	0	0	3	1	0
Investmentsⓘ	10	9	9	13	9	13	15	13	13	11
Inventories	41	44	53	55	72	70	79	85	97	109
Trade Receivables	47	34	55	80	77	60	54	92	86	91
Cash Equivalents ⓘ	77	82	136	126	132	228	274	847	775	786
Others Assetsⓘ	20	17	39	37	40	31	50	55	154	197
Total Assets ⓘ	303	285	403	411	427	488	551	1,166	1,201	1,275

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ	37	18	25	17	20	96	45	-25	-5	-4
PBT ⓘ	36	29	30	39	19	37	58	838	84	108
Adjustment ⓘ	10	10	13	10	7	-3	0	-803	-49	-81
Changes in Working Capital ⓘ	4	-13	-7	-19	4	42	-4	-44	-15	-3
Tax Paid ⓘ	-12	-8	-11	-13	-11	20	-9	-16	-25	-28
Cash Flow From Investing Activity ⓘ	-27	5	-23	10	-13	-77	-30	32	28	20
Capex	-17	-5	-4	-4	-12	-2	-3	-11	-10	10
Net Investments	-10	6	-17	6	-10	-94	-41	-580	-19	-56
Others ⓘ	0	5	-2	7	8	18	14	624	57	65
Cash Flow From Financing Activityⓘ	-11	-23	-7	-31	-10	-17	-10	-12	-22	-18
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-3	-3	-5	-3	-3	-2	-4	-3	-3	-4
Dividend Paid ⓘ	-4	-5	-4	-9	-9	-4	-8	-14	-14	-14
Others ⓘ	-3	-15	1	-19	2	-11	2	5	-5	0
Net Cash Flow ⓘ	0	0	-4	-4	-4	2	5	-6	2	-2

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	18.46	13.16	9.52	10.25	5.01	13.76	6.02	7.01	6.46	7.94
ROCE (%)	23.85	18.63	15.42	15.46	8.28	8.38	8.59	10.13	8.72	10.63
Asset Turnover Ratio	1.8	1.8	1.68	1.54	1.54	1.04	1.15	0.88	0.67	0.67
PAT to CFO Conversion(x)	1.61	0.95	1.39	0.71	1.67	2.59	2.37	-0.56	-0.08	-0.05
Working Capital Days
Receivable Days	32	28	28	39	44	52	35	35	41	39
Inventory Days	28	29	31	31	36	54	45	40	42	45
Payable Days	51	75	116	111	112	161	130	112	115	103

TTK Healthcare Ltd Stock News

TTK Healthcare Ltd FAQs

What is the share price of TTK Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of TTK Healthcare on 18-Jul-2025 16:59 is ₹1,324.7.

What is the market cap of TTK Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Jul-2025 16:59 the market cap of TTK Healthcare stood at ₹1,871.9.

What is the P/E ratio of TTK Healthcare?

The latest P/E ratio of TTK Healthcare as of 18-Jul-2025 16:59 is 22.92.

What is the P/B ratio of TTK Healthcare?

The latest P/B ratio of TTK Healthcare as of 18-Jul-2025 16:59 is 1.76.

What is the 52-week high and low of TTK Healthcare?

The 52-week high of TTK Healthcare is ₹1,923 and the 52-week low is ₹991.0.

What is the TTM revenue of TTK Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of TTK Healthcare is ₹801.5 ( Cr.) .

About TTK Healthcare Ltd

T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research.

TTK Healthcare has an All India sales and distribution network for marketing not only their own products, but also the KIWI Brand (Shoecare), Brylcreem (Haircare) and Kohinoor and Durex brands (Contraceptives). The company also specializes in sales and distribution in India as a joint venture partner. It has a successful tie up with Sara Lee Household and Bodycare Pvt. Ltd. and TTK-LIG Ltd. The company's distribution network comprises of 2800 redistribution stockists who cover both the urban and rural consumers.

TTK Healthcare has three Strategic Business Units

Pharamaceuticals Divison - TTK Healthcare's Pharmaceuticals Division has many breakthrough herbal and allopathic formulations, across various therapeutic segments. The range includes calcium supplements, haematinics, cervical dilators, thrombolytic agents, rejuvenators, multimineral supplements, liver correctives and pain management products.
Consumer Products Division - The Consumer Products Division(CPD) markets and distributes Woodward's Gripe Water - the undisputed market leader in the baby care category - and the recently introduced Woodward's Baby Soap. Besides handling the national distribution of Durex and Kohinoor condoms, the division also distributes Brylcreem Haircare and Toiletry Products and Kiwi's shoe care range.
Biomedical Devices Division- The TTK Heart Valve Division manufactures and distributes India's first indigenous heart valve prosthesis - the tilting-disc TTK Chitra Heart Valve. The only Indian-made heart valve, it is also the most price-friendly and so far nearly 18,000 Chitra valves have been successfully implanted in patients. Initially conceived in 1978, the heart valve being a critical implant, went through the most painstaking development for 12 years at the prestigious Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, India - an autonomous institute under the Department of Science and Technology, Government of India.

TTK the three letters that stand for quality consumer products at affordable prices. A reputation built across eight decades. An organization that started out as an indenting agency and grew to what it is today with path-breaking marketing ideas. Those core values that created TTK into a force to be reckoned with continue to define the framework of the TTK Group even today.

Product range of the company includes:

Personal care- Eva range of womenâ€™s personal care products

Pharmaceuticals

Calcium Supplement Range
Delivery Care Range
Women's Care Range
Haematinic Range
Pain Management Range
Neurotrophic Range
Gastro Intestinal Range
Male Fertility Range
Nutritional Range
Cardiac Care Range

Baby Care:

Woodwardâ€™s Baby Bath
Woodwardâ€™s Gripe Water

Animal Care

Livestock- Wide range of medicines, tonics and productivity boosters.
Poultry- High quality medicines and feed supplements for good productivity
Medicines, tonics and supplements for Pets.

Heart Valve - India's first indigenous heart valve prosthesis - the tilting-disc TTK Chitra Heart Valve.

Food - TTK Ready-to-fry Snack Pellets are available in a variety of flavors, shapes, colours and designs

Maps- The Publications Division of TTK Healthcare is the largest producer of maps and map-based publications in the private sector.

Achievements/ recognition:

Besides being the first pharmaceutical company in India to be awarded the ISO certification by BIS, TTK Healthcare was also the first to launch technology-driven life-saving products like Urokinase and Dopamine.
The first company to launch technology driven life saving products like Urokinase and Dopamine
The first to develop a product based on traditional knowledge - LACTARE for Lactation

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

TTK Healthcare Ltd - Stock Valuation and Financial Performance

TTK Healthcare Share Price

TTK Healthcare Ltd - Stock Valuation and Financial Performance

TTK Healthcare Share Price

DeciZen - make an informed investing decision on TTK Healthcare Share

Overall Rating ⓘ

1. Quality

2. Valuation

3. Price Trend

TTK Healthcare stock performance -

Is TTK Healthcare Ltd an attractive stock to invest in?

1. Is TTK Healthcare Ltd a good quality company?

2. Is TTK Healthcare Ltd undervalued or overvalued?

3. Is TTK Healthcare Ltd a good buy now?

10 Year X-Ray of TTK Healthcare: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - TTK Healthcare Ltd.

Management X-Ray of TTK Healthcare: Share

Shareholding Pattern

Promoter's Holding & Share Pledging